ACTRN12613000002785已完成1 期
Cytisine as a smoking cessation aid: measuring blood levels, craving, withdrawal and mood over a course of treatment
niversity of Auckland0 个研究点目标入组 12 人开始时间: 2013年1月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •They will be eligible for inclusion in the trial if:
- •- they are at least 18 years of age,
- •- they are able to provide written consent,
- •- willing to attempt to quit smoking
- •- are currently a regular smoker.
排除标准
- •-pregnant or breastfeeding,
- •-current users of NRT products,
- •-current users of non-NRT smoking cessation therapies (e.g. buproprion [registered tradename Zyban], clonidine, nortriptyline, or varenicline [registered tradename Champix]),
- •-enrolled in another smoking cessation programme
- •-have had a heart attack, stroke, or severe angina within the previous two weeks,
- •-have uncontrolled high blood pressure (> 150 mmHg systolic, > 100 mmHg diastolic),
- •-have phaeochromocytoma,
- •-suffer from schizophrenia.
- •-have severe renal impairment
- •-have had an adverse reaction to varenicline or cytisine
研究者
相似试验
尚未招募
2 期
Cytisine versus nicotine for smoking cessation in hospitalized psychiatric patients.IRCT20100127003210N16Shahid Beheshti University of Medical Sciences60
尚未招募
3 期
Efficacy of CYTISINE for Smoking Cessation through Downward Titration versus Simplified Three times daily Regimen : Open-label Randomized Clinical TrialSmokerscytisine,Smokers ,Smoking CessationTCTR20240711001Thai Health Promotion Foundation120
招募中
不适用
Analysis and Evaluation of Smoking Treatment With CytisineModerate or Severe Tobacco Use DisorderNCT06439303Regina Elena Cancer Institute65
终止
1 期
Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)Smoking CessationNCT02585024University of Auckland, New Zealand35
进行中（未招募）
1 期
Cytisine in prolonged dosage versus Nicotine Replacement Therapy in nicotine-dependent patients with Chronic Kidney Disease - single-center, randomized, non-inferiority clinical trial.icotine dependence, Chronic Kidney DiseaseMedDRA version: 20.0Level: PTClassification code: 10057852Term: Nicotine dependence Class: 100000004873MedDRA version: 21.1Level: PTClassification code: 10064848Term: Chronic kidney disease Class: 100000004857CTIS2023-509235-39-00arodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy292